Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Del Giudice, I
Right arrow Articles by Catovsky, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Del Giudice, I
Right arrow Articles by Catovsky, D
Haematologica, Vol 90, Issue 2, 268-270
Copyright © 2005 by Ferrata Storti Foundation

Letter

Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia

I Del Giudice, E Matutes, N Osuji, N Parry-Jones, J Swansbury, and D Catovsky

We retrospectively reviewed time to response and incidence of delayed responses in 13 patients with lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia (LPL/WM) treated with fludarabine with or without cyclophosphamide. During follow-up post-treatment, seven delayed responses (54%) were observed, improving the initial overall response rate of 61% to a final response rate of 77%.




HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2005 by the Ferrata Storti Foundation.